Cybin (HELP) Accumulated Expenses (2020 - 2025)
Cybin (HELP) reported Accumulated Expenses of $14.9 million for Q1 2025, up 105.14% on a YoY basis from $7.3 million in Q1 2024, and up 56.71% quarter-over-quarter from $9.5 million in Q4 2024.
Cybin (HELP) Accumulated Expenses (2020 - 2025) Analysis & Trends
Cybin has reported Accumulated Expenses for 6 years, with the latest figure at $14.9 million in Q1 2025.
- For the quarter ending Q1 2025, Accumulated Expenses rose 105.14% year-over-year to $14.9 million; the trailing twelve-month figure through Mar 2025 stood at $14.9 million (up 105.14% YoY), and the FY2025 full-year result was $15.4 million, up 111.74% from the prior year.
- Accumulated Expenses for Q1 2025 stood at $14.9 million, up from $9.5 million in the prior quarter.
- The five-year high for Accumulated Expenses was $14.9 million in Q1 2025, with the low at -$3.8 million in Q2 2024.
- Historically, Accumulated Expenses has averaged $1.7 million across 5 years, with a median of $250136.0 in 2023.
- Annual changes were most pronounced in 2023 — Accumulated Expenses soared 1016.53% — and 2024, when it slumped 1620.53%.
- Cybin's Accumulated Expenses stood at $330027.8 in 2021, then sank by 299.34% to -$657875.7 in 2022, then plunged by 370.39% to -$3.1 million in 2023, then soared by 407.8% to $9.5 million in 2024, then jumped by 56.71% to $14.9 million in 2025.
- The last three Accumulated Expenses figures came in at $14.9 million (Q1 2025), $9.5 million (Q4 2024), and -$1.9 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 14.93 Mn |
| Dec 31, 2024 | 9.53 Mn |
| Sep 30, 2024 | -1.88 Mn |
| Jun 30, 2024 | -3.80 Mn |
| Mar 31, 2024 | 7.28 Mn |
| Dec 31, 2023 | -3.09 Mn |
| Sep 30, 2023 | 2.67 Mn |
| Jun 30, 2023 | 250,136.03 |
| Feb 28, 2023 | -832,987.29 |
| Dec 31, 2022 | -657,875.73 |
| Sep 30, 2022 | -291,363.57 |
| May 31, 2022 | 685,597.27 |
| Feb 28, 2022 | 2.46 Mn |
| Dec 31, 2021 | 330,027.81 |
| Sep 30, 2021 | -336,035.14 |
| Jun 30, 2021 | 210,703.53 |
| Mar 31, 2021 | 2.21 Mn |
| Dec 31, 2020 | 630,518.93 |
| Sep 30, 2020 | 643,113.09 |
| Jun 30, 2020 | 929,631.89 |